Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Today

  • Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

    Virtual - Americas - EST , United States

    In this 90-minute training, you’ll learn how to do drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands. Using public data from GTEx (normal tissue), GEO, cancer collections and more, you’ll learn how to use Omicsoft Lands to: • Investigate a drug target or biomarker expression […]

  • Alacris Theranostics webinar on Comprehensive Molecular Tumor Analysis
    Featured

    Comprehensive Molecular Tumor Analysis with Alacris Theranostics

    Virtual - Americas - EST , United States

    Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However, deeper molecular insights are needed to […]

  • Lowering NGS analysis cost at lightspeed

    Virtual - Americas - EST , United States

    Advances in next-generation sequencing (NGS) technologies over the years have significantly decreased the cost of whole genome (WGS) and whole exome (WES) applications, such that they are considered the standard of care within multiple healthcare organizations. Arguably, the most significant NGS challenges lie within data analysis and interpretation. Various parameters such as sensitivity, specificity, cost […]

  • Featured

    How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD

    Virtual - Americas - EST , United States

    Across clinical oncology applications, from molecular testing to cancer research, the ability to identify potentially actionable genomic and genetic alterations to exploit the molecular vulnerabilities of cancer is a burgeoning field. Due to the sporadic nature of somatic cancers and the expansion of next-generation sequencing, the number of variants detected through tumor testing is growing […]

  • Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome, proteome, and metabolome. Through a series of brief technical vignettes, it is demonstrated how to: · Generate associations among molecular signatures obtained via integrating multi-omics data · Extract mechanisms from […]